Status:
TERMINATED
Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
Vitrolife
XVIVO Perfusion
Conditions:
Emphysema
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this research study is to perfect the technique of EVLP and learn about the safety of transplanting lungs that have been ventilated (attached to a breathing machine or ventilator to del...
Eligibility Criteria
Inclusion
- Lung Recipient
- A recipient must meet the following requirement to enroll into the study:
- Requires a single or bilateral lung transplant and is listed for lung transplant at UNC.
- Male or Female, 18 years of age or older.
- Subject or Subject's Representative provides a legally effective informed consent.
- Recipient does not have HIV, active Hepatitis or is colonized with Burkholderia cepacia.
- Potential subjects who have undergone previous lung transplants and meet all other inclusion criteria are eligible for study participation.
- Lung Recipient
Exclusion
- Recipient fails to meet standard of care requirements for lung transplant, or decides not to participate.
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT01241942
Start Date
December 1 2010
End Date
March 1 2013
Last Update
July 13 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UNC Hospitals
Chapel Hill, North Carolina, United States, 27599